Androgenic alopecia support
Adamite Follica X
A premium scalp formula designed to support hair-loss protocols with a science-led narrative focused on circulation, stimulation, and growth support.
Category
Mesotherapy
Technology
Dutasteride + Growth Factors
Positioning
Androgenic alopecia support
Indications
- Androgenic alopecia
- Hair loss
- Enhance scalp blood circulation
- Stimulates hair growth
Active ingredients
- Dutasteride 0.01%
- Growth factors
- Caffeine
- Minerals
- Vitamin B complex
Product summary
Adamite Follica X is positioned for premium aesthetic practice use with a clinical narrative built around trust, clarity, and refined presentation.
More details
Hair restoration science
Comprehensive therapeutic strategy for androgenetic alopecia.
This formula targets the core biological mechanisms of hair loss with a triple-action approach designed to support hormonal control, follicular stimulation, and regenerative activation.
Clinical positioning
Androgenetic alopecia is driven mainly by DHT. The condition is associated with anagen phase shortening, hair shaft diameter reduction, follicular miniaturization, and increased telogen shedding.
Pathway Target
DHT suppression, follicular stimulation, and regenerative support
Active Components
Dutasteride 0.01%, Caffeine, Growth Factors
Expected Progress
Reduced shedding in 4-6 weeks and visible density improvement by ~3 months
Understanding AGA
Androgenetic alopecia is driven mainly by DHT. The condition is associated with anagen phase shortening, hair shaft diameter reduction, follicular miniaturization, and increased telogen shedding.
Why DHT Matters
DHT is the central pathogenic driver in AGA. The cascade begins with testosterone conversion through 5α-reductase, followed by androgen receptor binding and progressive follicular miniaturization.
Triple-Action Formula
The formula combines three synergistic mechanisms: hormonal control with dutasteride, metabolic stimulation with caffeine, and regenerative activation through growth factors.
Clinical Protocol
Intradermal microinjections are distributed across affected scalp regions with precise depth and spacing (clinician workflow).
Safety & suitability
- Not suitable for pregnant or breastfeeding women
- Use only under professional supervision with appropriate medical screening
Hormonal Control
Dutasteride suppresses DHT and helps prevent follicular miniaturization.
Metabolic Support
Caffeine enhances microcirculation and supports follicular metabolism.
Regenerative Activation
Growth factors support angiogenesis and dormant follicle reactivation.
Protocol Timing
Reduced shedding may be observed in 4–6 weeks, with visible density improvement by around 3 months.
Clinical Use
Positioned for premium scalp protocols within a science-led aesthetic practice.
Scientific closing message
The product offers a comprehensive therapeutic strategy for androgenetic alopecia by combining hormonal, metabolic, and regenerative pathways in a targeted intradermal protocol.
Premium positioning for modern aesthetic practices.
Adamite Follica X is presented as part of a curated portfolio built to communicate trust, elegance, and scientific confidence across every touchpoint.
Brand summary
Adamite Pharma combines clinical authority with refined aesthetics, and this product page is designed to reflect that balance in a more premium, high-contrast presentation.